Page 133 - GHES-3-1
P. 133

Global Health Economics and
            Sustainability
                                                                        Adherence to ART among HIV patients in Cameroon



            Table 5. Therapy‑related factors associated with poor adherence to ART
            Explanatory variables              Adherence to ART                  OR (95% CI)           P‑value
                                      Good (n=150)         Poor (n=159)
            Discomfort when taking medication
             No                              78 (52)               24 (15)       1
             Yes                             72 (48)               135 (85)      6.09 (3.59 – 10.62)   <0.001***
            Difficulty getting used to therapy
             No                              69 (46)               33 (21)       1
             Yes                             81 (54)               126 (79)      3.25 (1.98 – 5.41)    <0.001***
            Duration of ART (years)
             >10                             3 (2)                 18 (11)       18 (3.41 – 131.08)    <0.001***
             1 – 5                           54 (36)               18 (11)       1
             6 – 10                          9 (6)                 3 (2)        1 (0.20 – 3.78)        1
             <1                              84 (56)               120 (75)      4.28 (2.38 – 7.99)    <0.001***
            Fear that ART will no longer work in the future
             No                              90 (60)               93 (58)      1
             Yes                             60 (40)               66 (42)       1.06 (0.67 – 1.67)    0.787
            Taking the tablets is a reminder of unwanted HIV status
             No                              60 (40)               21 (13)       1
             Yes                             90 (60)               138 (87)      4.38 (2.52 – 7.83)    <0.001***
            Side effects of this therapy
             No                              120 (80)              132 (83)      1
             Yes                             30 (20)               27 (17)       0.81 (0.45 – 1.45)    0.494
            Taking treatment other than ART
             No                              102 (68)              78 (49)       1
             Yes                             48 (32)               81 (51)       2.20 (1.39 – 3.52)    0.008 ***
            Reminder to take the medication
             Family                          6 (4)                 15 (9)        1
             Myself                          144 (96)              144 (91)      0.4 (0.13 – 1.01)     0.065
            ART regimen
             First-line                      150 (100)             153 (96)      1
             Second-line                     0                     6 (4)        1.02 (8.e-01 – 1.27)   0.979
            Using reminder tools for therapy
             No                              48 (32)               9 (6)         1
             Yes                             102 (68)              150 (94)      7.84 (3.85 – 17.73)   <0.001***
            Last viral load result
             Detectable                      24 (16)               27 (17)       0.93 (0.50 – 1.69)    0.816
             Undetectable                    126 (84)              132 (83)      1
            Notes: *p<0.05; **p<0.01; ***p<0.001.
            Abbreviations: OR: Odds ratio; CI: Confidence interval; HIV: Human immunodeficiency virus; ART: Antiretroviral therapy.

            in Nigeria and can be  explained by the potential for   associated with drug use can divert patients’ attention from
            stimulants, such as cocaine or amphetamines, to disrupt   their treatment, preventing them from proper compliance.
            the regularity of treatment intake. These substances often   In addition, certain drug interactions between excitants
            have a disinhibiting effect and can lead patients to forget   and antiretroviral drugs can compromise treatment
            or neglect their medication, particularly when their effects   efficacy, undermining the patient’s motivation to continue
            wear off. Moreover, the periods of descent and withdrawal   treatment.


            Volume 3 Issue 1 (2025)                        125                       https://doi.org/10.36922/ghes.4077
   128   129   130   131   132   133   134   135   136   137   138